Try our Advanced Search for more refined results
December 9, 2010
Track this case
Richard G. Andrews
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
Mylan Pharmaceuticals Inc. has settled a patent infringement suit brought by Shionogi Inc. and Andrx Corp. over Mylan's bid to develop a generic equivalent of Shionogi's blood glucose drug Fortamet, Mylan announced Wednesday.
Already a subscriber? Click here to login